Danny – Interview 26
Danny joined a trial of high blood pressure medication, but stopped because of side effects. She has concerns about the way some staff communicated with her and a lack of rapport and respect for her as a volunteer interested in her own health.
Danny’s husband had previously been in a big trial of medication for high blood pressure and cholesterol. Through the monitoring on the trial he had discovered he had type 2 diabetes, so they both felt being in a trial could benefit their own health. The same research institute approached them about another placebo-controlled trial, and they both volunteered. When they were screened, Danny’s husband turned out not to be eligible to take part because his blood pressure was normal, which they felt showed how he had benefited from the last trial.
Danny was eligible, but told the staff running the trial that she had previously developed an unpleasant dry cough as a side effect of one blood pressure tablet. If the same thing happened to her in the trial she said she would have to withdraw. Danny’s understanding was that for the first two weeks everyone would be given a placebo or dummy tablet, to see how they got on without medication, and then they would either continue on the placebo or be given the trial drug. Danny thought if she got side effects she would know she was taking the active drug.
She met with several problems during the trial. Firstly, she was surprised to discover that some of the people working on the trial were called research scientists; and it was unclear to her what their clinical qualifications were. She thinks it should be clearly explained to patients who they will meet. She had a good rapport with one research scientist, who she felt listened to her and took an interest in what she was saying about side effects, and was always willing to share information with her. This contrasted with one doctor, who would never tell her what her blood pressure measurements were, so she always looked in the file when he was out of the room. She thinks trial staff should remember that trial participants are volunteers who are interested in their health, and should be treated with respect and openness. They should answer any relevant questions.
The other research scientist struck her as uninterested and quite dismissive, and poorly informed about health and safety regulations. Danny felt she was being told off; on a few occasions about things that staff themselves had not made clear were important and which she did not remember being in the information leaflet. One was when she said she was going on holiday (in July), and so would not be there at exactly the right time for her next appointment. The research assistant suggested she might have to be excluded; from the trial – a word which reminded Danny of school exclusions for bad behaviour – though eventually a solution was found. Another occasion was when she brought back some unused tablets as requested, and they were not still in their original packaging, because Danny used daily medication boxes (left over from her husband’s trial) to help plan what tablets to take over several weeks. Again, she was given the impression that she had caused problems with their procedure. In both cases, Danny felt these were things which trial staff could reasonably have anticipated.
When she withdrew from the trial because of side effects, she felt dismissed as useless to the staff, rather than being thanked for at least trying. She believes people who volunteer for trials need a more equal relationship with trial staff than she experienced.